The purpose of this study was to determine if Pasteurella haemolytica can directly injure bovine pulmonary endothelial cells (EC) and if neutrophils have a beneficial or detrimental role in bacterium-EC interaction. Various combinations of live P. haemolytica, heat-killed P. haemolytica, anti-P. haemolytica immune serum, polymyxin B, and bovine neutrophils were added to confluent monolayers of bovine EC. Monitoring included determination of 51Cr release from EC, phase microscopy, and transmission electron microscopy. Although toxic changes were not evident at 5 h postinoculation, both live and heat-killed P. haemolytica produced extensive EC damage by 22 h postinoculation. Damage by live P. haemolytica was prevented only when both neutrophils and immune serum were used. Polymyxin B effectively prevented the toxic effect of heat-killed P. haemolytica, suggesting that lipopolysaccharide was the major toxic factor. Morphological studies showed close apposition of P. haemolytica to EC membranes, neutrophil activation, and adherence to EC but no evidence of neutrophil-associated EC membrane damage. These studies demonstrate that neutrophils and immune serum in combination are effective in preventing EC damage mediated by live P. haemolytica.
Pasteurella haemolytica (serotype 1, biotype A) is a common respiratory bacterial pathogen in cattle, causing an acute fibrinosuppurative pleuropneumonia (29) . The acute pulmonary lesions are characterized by alveolar edema, hemorrhage, neutrophilic and fibrinous exudate, and pulmonary vascular thrombosis (8, 29, 36) . These changes may progress to extensive areas of pulmonary parenchymal necrosis and formation of abscesses (29) .
The acute onset of alveolar edema, hemorrhage, and fibrinous exudate occurrence is consistent with pulmonary microvasculature injury (23) . Several P. haemolytica virulence factors have been identified, including capsular polysaccharide (9, 11) , leukotoxin (1, 2, 20, 35) , and lipopolysaccharide (LPS) (10, 18, 30, 37) . Although leukotoxin rapidly kills and lyses bovine neutrophils (PMN), it does not directly damage bovine endothelial cells (EC) in vitro (6) . However, bovine EC in vitro are very sensitive to the toxic effects of P. haemolytica LPS, whether in purified form or as a component of a bacterial culture preparation (6, 27) . LPS is probably important in the natural disease because it has been demonstrated near EC in pulmonary lesions caused by P. haemolytica (42) and intratracheal LPS inoculation in cattle results in significant pulmonary lesions (37) . PMN have been incriminated as major mediators of EC damage during acute inflammation (38) . The role of PMN in bovine pasteurellosis has been suggested as either detrimental or beneficial (8, 36) . However, recent in vitro studies clearly demonstrate that bovine PMN can protect bovine EC against low to moderate levels of LPS (5, 7 Bovine PMN. PMN were isolated from the peripheral blood of an adult Charolais-Hereford-cross steer as previously described (31) . The cell viability, determined with trypan blue, was >98%. The PMN were used immediately in experiments following isolation.
Bovine pulmonary EC cultures. Primary cultures of EC from the pulmonary artery were established by methods previously described (34) . The cells were verified as endothelial by typical cobblestone morphology and the presence of anti-factor VIII antigen on the cell surface as described previously (32) . The EC cytotoxicity assay. Toxicity of EC monolayers was determined by monitoring the release of 51Cr from labeled EC monolayers in 24-well tissue culture plates as previously described (21) . After the addition of various bacterial variables, monolayers were incubated at 37°C on an oscillating platform. Following a 5-or 22-h incubation the 51Cr release by EC was determined, and the cytotoxic index (CI) was calculated based on the following formula: [(A -B)I(C -B)]
x 100, where A is sample release, B is spontaneous release, and C is total release. All variables were tested in quadruplicate, and experiments were repeated to confirm results.
Electron microscopy of EC monolayers. Transmission electron microscopy (TEM) morphological studies of EC monolayers were done as previously described (33) . Briefly, monolayers were established on LUX coverslips in DMEM-10% FBS. Following the specified incubation period with bacterial variables, the wells were washed with Hanks balanced salt solution (HBSS), and cells were fixed with 2.0% glutaraldehyde for 60 min at 22°C and washed three times with cacodylate buffer. The coverslips were routinely processed for TEM embedding, sectioning, and staining and viewed on a Philips 201 transmission electron microscope.
Anti-P. haemolytica immune serum. An adult cow was inoculated subcutaneously two times, 2 weeks apart, with a live avirulent P. haemolytica (serotype 1) vaccine (Respirvac, Beecham Laboratories, Lincoln, Nebr.). The anti-P. haemolytica serum titers 2 weeks following the last inoculation were 1/6,400 against whole bacteria, 1/3,200 against bacteria without a capsule, 1/6,400 against bacterial capsular extract, 1/3,200 against leukotoxin (culture supernatant fluid), and 1/400 against P. haemolytica endotoxin. These titers were determined by enzyme-linked immunosorbent assay techniques with the various P. haemolytica antigens as previously described (28) .
Bacterium opsonization assay. Either live or heat-killed P. haemolytica (108 CFU/ml) was suspended in media containing either 10% FBS or 10% immune serum. One-milliliter volumes of bacterial suspension were then added to 107 PMN, mixed, and incubated at either 37 or 4°C on a rocker table. At the end of a 60-min incubation at 37 or 4°C, cytospin cytology preparations were made of all samples, air dried, and stained with Wright-Giemsa stain. The presence of bacteria associated with 200 PMN was determined by light microscopy of duplicate samples for each variable.
Statistical analysis. The CIs for different variables were compared by using the Duncan multiple-range test to determine significant (P <0.05) differences between groups.
RESULTS
Effects of live P. haemolytica on EC. To determine if P. haemolytica can directly damage bovine EC, we added several different concentrations of live P. haemolytica (103, 104, and 105 CFU/ml) to confluent EC monolayers. At 2 h PT no toxic changes were evident and monolayers were 100% confluent. At 5 h PT the 51Cr release CI was 0 (data not shown) and no morphological changes were evident in monolayers by phase-contrast microscopy or TEM. By 22 h PT all culture wells treated with the various bacterial concentrations were uniformly overgrown with bacteria, as indicated by medium turbidity and phase microscopy. The CI was similarly high for all three bacterial concentrations, ranging from 44 to 49 (Fig. 1) . Morphological changes at 22 h PT consisted of loss of EC monolayer confluency, numerous detached EC, and occasional retained elongated EC (Fig. 2B) , compared with total confluency of EC in control media ( Fig. 2A) .
The preincubation of live P. haemolytica for 60 min at 37°C with 500 U of polymyxin B per ml protected EC from bacterium-mediated toxicity (data not shown). The polymyxin B treatment resulted in a reduction of the EC CI from 72 to 0 for 104 CFU/ml, 80 to 0 for 105 CFU/ml, and 68 to 8 for 107 CFU/ml.
Influence of PMN on P. haemolytica-mediated EC damage.
To determine if the toxic effect of P. haemolytica on EC could be modulated with PMN or immune serum, a dose response for live P. haemolytica was determined on confluent EC monolayers with and without the presence of PMN and/or 10% immune serum. CIs after 22 h PT are shown in Fig. 3 . The immune serum by itself significantly lowered the CIs of bacterial concentrations of 104 and 105 CFU per well; however, optimal protection was produced by the combination of PMN and immune serum at all bacterial concentrations. PMN without immune serum did not significantly protect EC monolayers from P. haemolytica-mediated toxicity.
In the PMN-immune serum group, TEM morphological results at 2 h PT demonstrated bacteria within PMN (Fig.  2C) , although some extracellular bacteria were still associated with the EC surface (Fig. 2D) . PMN in both immune serum and control media groups had numerous cellular processes (pseudopodia), indicating activation (Fig. 2D) . The PMN were also adherent to EC surfaces, as indicated by the close apposition of PMN and EC and retention of PMN following TEM processing washes. By 22 h PT, all groups but the PMN-immune serum group had bacterial overgrowth (indicated by medium turbidity), less than 10% EC monolayer confluency, and only a few retained adherent cells. The EC monolayers treated with PMN 22 h PT with dead P. haemolytica (E; magnification, x230), and 22 h PT with dead P. haemolytica preincubated with 500 U of polymyxin B per ml (F; magnification, x230). In panels C and D, note bacteria (arrows).
plates incubated overnight at 37°C. The PMN-immune serum group had 0 CFU/ml compared with 1.4 x 109 CFU for the medium control, 6 .8 x 108 CFU for PMN only, and 3.6 x 108 CFU for immune serum only.
The immune serum was an effective opsonin of both live and dead P. haemolytica as evidenced by the obvious intracellular bacteria in PMN (Fig. 2C ) and quantitative bacterial opsonization data ( ever, by 22 h variable levels of EC toxicity were evident, dependent on the concentration of dead bacteria ( Table 2 ). The 104-CFU/ml dilution produced no morphological changes and a CI of 0. The 106-CFU/ml concentration resulted in a moderate loss of confluency and a CI of 14. The highest degree of toxicity was produced by 108 CFU/ml, with almost complete loss of monolayer confluency (Fig. 2E ) and a CI of 29. In the same experiment, live P. haemolytica produced a CI of 64 (data not shown). Simultaneous with bacterial inoculation, addition of immune serum (10%), PMN (106 per well), or both did not significantly affect the CI of EC treated with either 106 or 108 CFU of dead bacteria per ml ( Table 2 ). All groups had similar losses of confluency at 108 CFU per well.
To determine if the toxic factor of the dead bacteria was LPS, 500 U of polymyxin B per ml was preincubated for 60 min at 37°C with heat-killed bacteria. At 2, 5, or 22 h PT there was morphological evidence of only slight EC toxicity in polymyxin B treatments. (Fig. 2F) . The polymyxin B lowered the 106-CFU/ml from 14 to 4 and the 108-CFU/ml CI from 29 to 10 (Fig. 4) . The addition of PMN or immune serum in conjunction with polymyxin B resulted in decreases (Fig. 4) . DISCUSSION EC damage is an important event in the pathogenesis of bovine pulmonary pasteurellosis (6) . In addition to the histological evidence of alveolar edema, fibrinous exudate, and hemorrhage (8), pulmonary alveolar septal capillary thrombosis has been observed in calves 5 h following intrabronchial P. haemolytica inoculation (4b). The results of the present study clearly demonstrate that P. haemolytica can directly damage bovine pulmonary artery EC in vitro independent of bacterial viability, as evidenced by the EC toxicity caused by sufficient concentrations of heat-killed P.
haemnolytica. The 5'Cr CI varied between bacterial variables and did not approach 100% toxicity even though the EC morphologically appeared completely dead, as evidenced by detachment or cellular contraction or both. Perhaps variable amounts of 51Cr were retained in cytoplasmic organelles or plasma membranes despite cell death. The degree of EC damage by live bacteria was approximately double that of the dead bacteria, but this difference is probably due to the greater number of bacteria that are eventually generated in live cultures (109 to 109 5 CFU/ml) versus the concentration (6) . Other, as yet unidentified, bacterial toxins may be important in EC damage, but the one factor known to directly damage EC is LPS (6, 27) . Previous studies have demonstrated that purified P. haemolytica LPS directly kills bovine EC (6, 27) and this toxicity can be neutralized by preincubation with polymyxin B (6) . Polymyxin B binds to the lipid A moiety of LPS and effectively neutralizes many of the LPS-related biological actions (24) . The effective protection of EC from dead P. haemolytica obtained with polymyxin B supports the important role of LPS as the chief mediator of EC damage in pulmonary pasteurellosis.
Very few studies have been reported concerning in vitro effects of live bacteria on EC cultures. Some bacteria such as Escherichia coli do actively bind to EC via S fimbria components (26) , suggesting that bacterial adherence to EC may be important in the development of localized bacterial infections and evasion of the phagocytic clearance mechanism. A similar process may occur in the septicemic form of pulmonary pasteurellosis. Intravenous inoculation of P. haemolytica results in a fibrinopurulent pneumonia not unlike either the natural disease or that produced by an intratracheal bacterial inoculation (39) . Although bacterial adherence was not monitored in this study, the close apposition of bacteria to EC membranes, as evidenced in transmission electron micrographs, suggest that P. haemolytica adherence to pulmonary EC may be an important factor in disease pathogenesis. This would enable blood-borne P. haemolytica to localize in the lung and establish a pneumonic focus.
Phagocyte interaction with P. haemolytica greatly determines the progression of natural and experimental disease. Previous studies have shown that PMN may contribute to the severity of pneumonic lesions (8, 36) ; however, diffuse pulmonary edema and hemorrhage still occur in the absence of circulating PMN (8) . Results from the present in vitro study clearly show that PMN have a definite protective role in preventing EC damage by P. haemolytica. PMN in the presence of immune serum effectively phagocytized P. haemolytica and prevented EC damage. These results compare favorably with previous studies that showed that PMN in the proper PMNlbacterium ratio can phagocytize and kill P. haemolytica (14) . At high bacterium/phagocyte ratios (greater than 10) bacteria reduce PMN viability, presumably because of bacterial secretion of leukotoxin. Our EC toxicity studies did not include bacterium/phagocyte ratios greater than 1 to 10 because preliminary studies demonstrated consistent bacterial overgrowth of culture wells when higher concentrations of bacteria were used.
Both PMN and immune sera were necessary in our experiments to effectively kill P. haemolytica and prevent EC damage. These results agree with previous studies of the necessity of P. haemolytica opsonization with immune serum before PMN can effectively kill the bacteria (14) . In addition, our immune serum contained antileukotoxin antibodies which prevented the toxic effect of leukotoxin on PMN. Immune serum by itself, in our study, did have some protective effect against live P. haemolytica but not as complete as PMN and immune serum together. These results agree with previous studies which showed variable but incomplete effects of immune serum (4, 19) .
It was surprising that PMN and immune serum, either singularly or in combination, did not protect EC from the toxic effect of dead P. haemolytica. We had postulated that in the presence of opsonizing serum, PMN would effectively phagocytize the bacteria and either degraIe pr absorb LPS (25) . Bovine PMN contain acyloxyacyl hydrolase, which detoxifies LPS (22a). Possibly, the dead bacteria may have contained more LPS than PMN could effectively process and detoxify. This observation suggests that in the natural disease, P. haemolytica in adequate nuitnbers in the lung would result in EC damage regardless of effective phagocytosis by PMN.
In this and a previous study (7), we have shown that the presence of PMN is associated with protection of the EC against either P. haemolytica or related products. This is contrary to previous reports which suggest that PMN are important in mediating EC damage in acute inflammatory disease (16, 17, 21, 22, 40, 41) . The role of PMN in vascular damage apparently varies between in vitro culture conditions and perhaps between animal species. Our culture system contains 10% FBS, which contains components that protect EC from PMN-secreted oxygen radicals and lysosomal enzymes (41) . Lack of activated PMN-mediated EC damage in the presence of serum has also recently been shown in studies with equine PMN and EC (4a.) Bovine EC are also different from human EC in that bovine EC have an effective catalase system that prevents the toxic effect of PMN-secreted hydrogen peroxide (15) .
The results of the present study suggest that P. haemolytica can be controlled in the bovine lung provided that adequate PMN and immune serum are present and bacterial numbers are not in high concentration. However, as the numbers of bacteria increase resulting in higher LPS concentrations, EC are killed directly by the LPS or perhaps activated to a procoagulant state (3, 12, 13) .
